Mavyret 50 mg/1 (Glecaprevir and Pibrentasvir PELLET) 50 mg/1

Mavyret 50 mg/1 is a combination of Glecaprevir and Pibrentasvir, used for treating certain viral infections. This oral medication is manufactured by AbbVie Inc. in the USA.

Strength

50 mg/1

Pack Size

1 PACKET in 1 CARTON (0074-2600-28) / 28 PELLET in 1 PACKET

Manufacturer / TM Owner

AbbVie Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mavyret 50 mg/1 is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. This medication is designed to target and inhibit the virus, helping to reduce its presence in the body. It is often prescribed as part of a comprehensive treatment plan for HCV, which may include other medications and lifestyle changes.

Side Effects

Common effects of Mavyret 50 mg/1 may include fatigue, headache, and nausea. Some individuals might experience changes in taste or mild gastrointestinal discomfort. These effects vary from person to person and are not experienced by everyone who takes the medication.

Precautions & Warnings

Mavyret 50 mg/1 should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should be kept out of reach of children and pets.

Avoid Interactions

Mavyret 50 mg/1 may interact with certain medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances that affect liver function should be avoided while taking this medication.

References

Frequently Asked Questions

Mavyret 50 mg/1 is used for the treatment of chronic hepatitis C virus (HCV) infection.

Mavyret 50 mg/1 is taken orally, typically as directed by a healthcare professional.

Common effects may include fatigue, headache, and nausea.

It is important to consult a healthcare provider before taking Mavyret 50 mg/1 with other medications to avoid potential interactions.

Mavyret 50 mg/1 should be stored as directed, typically at room temperature and out of reach of children.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.